These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12724458)

  • 21. Interdependance of the level of the steady potential of the brain and visual evoked potentials in human aging: the norm and Alzheimer's disease.
    Fokin VF; Ponomareva NV
    Neurosci Behav Physiol; 1995; 25(2):136-41. PubMed ID: 7630497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The flash and pattern VEP as a diagnostic indicator of dementia.
    Wright CE; Harding GF; Orwin A
    Doc Ophthalmol; 1986 Jan; 62(1):89-96. PubMed ID: 3956362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer's disease patients.
    Pollock VE; Schneider LS; Chui HC; Henderson V; Zemansky M; Sloane RB
    Biol Psychiatry; 1989 Apr; 25(8):1003-13. PubMed ID: 2720014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual evoked responses in Alzheimer's disease: a review.
    Moore NC
    Clin Electroencephalogr; 1997 Jul; 28(3):137-42. PubMed ID: 9241466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flash and pattern reversal visual evoked responses in normal and demented elderly.
    Brodie EE; Allan D; Brooks DN; McCulloch J; Foulds WS
    Cortex; 1992 Jun; 28(2):289-93. PubMed ID: 1499313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
    Robles A; Touriño R; Gude F; Noya M
    Funct Neurol; 1999; 14(4):203-7. PubMed ID: 10713893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain event-related potentials: diagnosing early-stage Alzheimer's disease.
    Chapman RM; Nowlis GH; McCrary JW; Chapman JA; Sandoval TC; Guillily MD; Gardner MN; Reilly LA
    Neurobiol Aging; 2007 Feb; 28(2):194-201. PubMed ID: 16430992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal visual evoked potentials in Alzheimer's disease: a preliminary report.
    Swanwick GR; Rowan M; Coen RF; O'Mahony D; Lawlor BA; Walsh JB; Coakley D
    Biol Psychiatry; 1996 Mar; 39(6):455-7. PubMed ID: 8679793
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurophysiologic analyses of low- and high-level visual processing in Alzheimer disease.
    Fernandez R; Kavcic V; Duffy CJ
    Neurology; 2007 Jun; 68(24):2066-76. PubMed ID: 17562827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Landscape test for assessing visual memory in Alzheimer's disease].
    Valls-Pedret C; Olives J; Bosch B; Caprile C; Castellví M; Molinuevo JL; Rami L
    Rev Neurol; 2011 Jul; 53(1):1-7. PubMed ID: 21678318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of scopolamine on visual evoked potentials in aging and dementia.
    Ray PG; Meador KJ; Loring DW; Murro AM; Buccafusco JJ; Yang XH; Zamrini EY; Thompson WO; Thompson EE
    Electroencephalogr Clin Neurophysiol; 1991; 80(5):347-51. PubMed ID: 1716558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuroimmune interactions in normal aging and in Alzheimer disease].
    Ponomareva NV; Fokin VF; Androsova LV; Koliaskina GI; Selezneva ND; Gavrilova SI
    Vestn Ross Akad Med Nauk; 1995; (12):27-32. PubMed ID: 8664599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Validity of the Spanish version of the Addenbrooke's Cognitive Examination for the diagnosis of dementia and to differentiate Alzheimer's disease and frontotemporal dementia].
    Sarasola D; de Luján-Calcagno M; Sabe L; Crivelli L; Torralva T; Roca M; García-Caballero A; Manes F
    Rev Neurol; 2005 Dec 16-31; 41(12):717-21. PubMed ID: 16355355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of event-related potentials in cognitive decline in Alzheimer's disease.
    Lai CL; Lin RT; Liou LM; Liu CK
    Clin Neurophysiol; 2010 Feb; 121(2):194-9. PubMed ID: 20005164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.
    Testa JA; Ivnik RJ; Boeve B; Petersen RC; Pankratz VS; Knopman D; Tangalos E; Smith GE
    J Int Neuropsychol Soc; 2004 Jul; 10(4):504-12. PubMed ID: 15327729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer's dementia.
    Crow RW; Levin LB; LaBree L; Rubin R; Feldon SE
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):875-8. PubMed ID: 12556424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?
    Katz B; Rimmer S; Iragui V; Katzman R
    Ann Neurol; 1989 Aug; 26(2):221-5. PubMed ID: 2774509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of eye closure on the flash visual evoked potentials in Alzheimer's disease.
    Bandini F; Tartaglione A
    Int J Psychophysiol; 2005 Sep; 57(3):155; author reply 157. PubMed ID: 15949860
    [No Abstract]   [Full Text] [Related]  

  • 40. Psychophysical and electrophysiological testing in ocular hypertension.
    Nebbioso M; Gregorio FD; Prencipe L; Pecorella I
    Optom Vis Sci; 2011 Aug; 88(8):E928-39. PubMed ID: 21532514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.